Skip to main content
Erschienen in: Perioperative Medicine 1/2019

Open Access 01.12.2019 | Research

Perioperative antibiotic prescribing in surgery departments of two private sector hospitals in Madhya Pradesh, India

verfasst von: Anna Machowska, Jonatan Sparrentoft, Shyam Kumar Dhakaita, Cecilia StålsbyLundborg, Megha Sharma

Erschienen in: Perioperative Medicine | Ausgabe 1/2019

Abstract

Background

Single-dose perioperative antibiotic prophylaxis (PAP) is recommended for clean, non-infectious surgeries to prevent surgical site infections. However, the common practice of unindicated use and prolonged use of antibiotics contributes to the development and spread of antibiotic resistance (ABR). The present study explores the perioperative use of antibiotics among inpatients with surgical indications at surgery departments of a teaching (TH) and a non-teaching (NTH) tertiary care hospital in Madhya Pradesh, India.

Methods

Data was collected manually for all inpatients for 3 years (April 2008–August 2011). Patients with non-infectious surgical indications were selected for detailed analysis at the diagnosis group level.

Results

Out of 12,434 enrolled inpatients (TH 6171 and NTH 6263), the majority (> 85%) received antibiotics. None of the inpatients received the recommended single-dose PAP. The average duration of antibiotic treatment was significantly longer at the TH compared to the NTH (9.5 vs 4.4 days, p < 0.001). Based on the study aim, 5984 patients were classified in four diagnosis groups: upper or lower urinary tract surgery indications (UUTSI and LUTSI), and routine or emergency abdominal surgery indications (RASI and EASI). In both hospitals, quinolones were the most prescribed antibiotics for UUTSI (TH 70%, NTH 37%) and LUTSI (TH 70%, NTH 61%) antibiotic. In the TH, aminoglycosides (TH 32%) were commonly prescribed for RASI and imidazole derivatives (75%) for EASI. In the NTH, cephalosporins (39%) and imidazole derivatives (56%) were the most prescribed in RASI and EASI, respectively.

Conclusions and recommendations

High prescribing of antibiotics in all four selected diagnoses groups was observed at both hospitals. In spite of the recommended single-dose PAP, antibiotics were mainly prescribed for longer durations. The unrecommended use of antibiotics is a risk factor for the development of AMR. Improving the quality of antibiotic prescribing by a stewardship program focusing on the development and implementation of local prescribing guidelines is needed.
Hinweise
Anna Machowska and Jonatan Sparrentoft contributed equally for this study and share the first authorship.
Cecilia StålsbyLundborg and Megha Sharma contributed equally for this study and share the last authorship.
A correction to this article is available online at https://​doi.​org/​10.​1186/​s13741-019-0123-1.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ABR
Antibiotic resistance
ATC
Anatomical Therapeutic Chemical
CDC
Centers for Disease Control and Prevention
DDD
Defined daily doses
EASI
Emergency abdominal surgery indications
FDCs
Fixed-dose combinations
HAIs
Healthcare-associated infections
HIC
High-income countries
ICD 10
International Statistical Classification of Diseases and Related Health Problems - Tenth Revision
LMIC
Low- and middle-income countries
LUTSI
Lower urinary tract surgery indications
NLEMI
National List of Essential Medicines of India
NTH
Non-teaching hospital
PAP
Perioperative antibiotic prophylaxis
RASI
Routine abdominal surgery indications
SSIs
Surgical site infections
TH
Teaching hospital
UTI
Urinary tract infection
UUTSI
Upper urinary tract surgery indications
WHO
World Health Organization
WHOLEM
WHO List of Essential Medicines

Background

Antibiotic resistance (ABR) is a definite result of antibiotic use and a condition when common infections or minor injuries can turn into life-threatening situations. Therefore, ABR is one of the major challenges to public health, globally (Gagliotti et al. 2011). Unavailability or poor implementation of antibiotic prescribing guidelines and constrained resources are major contributors to the development and spread of ABR. Prescribing antibiotics for a specific indication according to the local prescribing guidelines enhances effectiveness of the treatment. Development of local prescribing guidelines based on surveillance of antibiotic prescribing and resistance patterns is recommended. Acceptance of the guidelines by the prescribers is essential to assure the compliance of the guidelines. Various strategies have been applied globally, to improve prescribing and compliance, such as computerized registers for the surveillance and follow-up of the prescriptions and offering financial incentives to the prescribers (Gould 2002; Bou-Antoun et al. 2018). However, resource-constrained healthcare facilities of low- and middle-income countries (LMICs) cannot follow most of these strategies and depend on the use of human resources. Manual collection of antibiotic prescribing data for a long time period even with the help of available World Health Organization (WHO) tools is an expensive, time-consuming, and cumbersome process (World Health Organization 2017a).
India is an infection prone country wherein 2011, 30% of all hospital mortalities were reported due to infectious diseases (Ganguly 2011; Census of India 2011). Healthcare facilities are the main source of healthcare-associated infections (HAIs); therefore, high use of antibiotics is anticipated at these settings. HAIs increase morbidity rates, healthcare costs, and mortalities (Chandy et al. 2014; Shojania et al. 2001). In India, 93% of all healthcare facilities belong to the private healthcare sector. Thus, this sector plays a significant role to provide healthcare and medical services and also to the overall increase of antibiotic consumption and resistance in the country (P C. Healthcare in India 2009; Deshpande et al. 2004; World Health Organization 2009). Despite this, little is known about antibiotic prescribing patterns in high infection risk units of the facilities (Sharma et al. 2012). The patients undergoing surgery are at high relative risk of a most common form of HAIs, i.e., the surgical site infections (SSIs) (World Health Organization 2011; Alp et al. 2014). Prescription of antibiotics as perioperative antibiotic prophylaxis (PAP) is recommended to prevent SSIs. PAP is the limited number of antibiotic doses administered along with preoperative preparation, during or after surgeries, in an aseptic condition and postoperative wound care in order to prevent the suspected SSIs (Hohmann et al. 2012). PAPs are recommended to discontinue after 24 h of surgery, in the absence of a known infection (Crader and Bhimji 2018). Thus, analysis of the constituents of the PAP and assessment of prescribing of antibiotics based on the indications is crucial.
The overall use of antibiotics is at the rapid rise in India where beta-lactam antibiotics and quinolones are the most commonly used classes (World Health Organization 2011; World Health Organization 2012). Although least investigated, yet extensive PAP practices in India could be presumed in view of reports of high antibiotic prescribing (Sharma et al. 2012; Van Boeckel et al. 2014; Alvarez-Uria et al. 2014). Studies conducted at surgery departments of two Indian healthcare settings presented that nearly 90% of the inpatients were prescribed antibiotics and SSI rate was 5% in one of the settings (Sharma et al. 2012; Pathak et al. 2014). In a study conducted at the study setting between 2010 and 2013, the SSI rate ranged between 5 and 6.5% (Lindsjo et al. 2015). Despite a paucity of antibiotic prescribing surveillance studies from India, rapid development and spread of ABR could be anticipated due to extensive use of antibiotics. This stimulates to conduct a study on antibiotic prescribing in high infection risk departments such as surgery department at Indian healthcare facilities (Hawkey 2008). The resistance situation is worrisome as previous studies from the settings based on 716 isolates from 2568 patient showed that 69% of E.coli and 41% of Klebsiella pneumoniae isolates were ESBL producers. The isolates had high resistance to fluoroquinolones and beta-lactams except for imipenem and piperacillin-tazobactam. Methicillin-resistant Staphylococcus aureus (MRSA) showed high resistance to ciprofloxacin, co-trimoxazole, and levofloxacin (Pathak et al. 2012).
Thus, the aim of the present study is to explore the perioperative use of antibiotics among inpatients with the most common surgical indications at surgery departments of a teaching (TH) and a non-teaching (NTH) tertiary care hospital in Ujjain district of Madhya Pradesh, India.

Methods

Study setting

Surgery departments of two private, tertiary care hospitals run by a trust in Ujjain district, Madhya Pradesh, India, were included in the study. The Chandrikaben Rashmikant Gardi Hospital, a rural-based teaching hospital (TH), is located in the village Surasa and has 5 operation theaters and 130 beds at the surgery departments. The TH is run on a charity basis where healthcare services and medications are provided free of cost to all in- and outpatients. All medicines are procured by the management. The Ujjain Charitable Trust Hospital, the urban-based non-teaching hospital (NTH), is located in the city of Ujjain and has 36 beds at the surgery department and 5 operation theaters. At the NTH, the healthcare services are available at a subsidized rate yet patients have to pay for all prescribed medicines out-of-pocket.

Data collection and analysis

This was a cross-sectional observational study with data collected over 3 years. Data was recorded manually for all patients admitted to the surgery department using a customized data collection tool. The nursing staff was trained for data collection (Sharma et al. 2012). Information such as demographic details; hospitalization dates; all diagnoses (indications), written by the treating surgeon; and details of prescribed antibiotics were recorded from the patients’ file. All diagnoses were coded according to the International Statistical Classification of Diseases and Related Health Problems-Tenth Revision (ICD-10) (World Health Organization 2010). Specifically trained persons fill in the generic names and Anatomical Therapeutic Chemical classification (ATC) codes of the antibiotics that were prescribed by brand names (World Health Organization 2017a). The ATC codes of new FDCs that were not recognized by the WHO were assigned by the authors in agreement with WHOCC in Norway (Sharma et al. 2012). Defined daily doses (DDD) prescribed per day were calculated for prescribed antibiotics (World Health Organization 2017a). Antibiotic prescriptions were analyzed for the adherence to the WHO List of Essential Medicines (WHOLEM) (World Health Organization 2017b) and the National List of Essential Medicines of India (NLEMI) (Directorate General of Health Services MoHaFW, Government of India 2011). The analysis was conducted at the substance level of the ATC for selected diagnoses groups of the patients (World Health Organization 2017a).
The surgeries of the urinary tract and abdominal surgeries were most common in the settings. Patients who underwent these most commonly performed surgical procedures but had no suspected bacterial infections were selected for detailed analysis. In total, 5984 who had urinary tract and abdominal surgeries were selected and grouped in four diagnoses groups, namely upper urinary tract surgery indications (UUTSI), lower urinary tract surgery indications (LUTSI), routine abdominal surgery indications (RASI), and emergency abdominal surgery indications (EASI). As the patients appearing for emergency abdominal surgery are unique in terms of varied risk factors than the routine surgeries, thus, they were grouped and analyzed separately. All patients who had simultaneous diagnoses in the ICD-10 group A (721), i.e., bacterial infections; ICD-10 group B (105), i.e., other infections group; and urinary tract infections (UTIs) from ICD-10 group N were excluded from the analysis. No national PAP guidelines are available in India; therefore, international guidelines were used as a reference in the present communication (World Health Organization 2016). The selection process for detailed analysis is presented as a flowchart in Fig. 1, according to the STROBE guidelines (Strengthening the Reporting of Observational studies in Epidemiology-STROBE statement n.d.).

Inclusion and exclusion criteria

Overall, 12,992 patients were admitted to the surgery departments during 2008–2011 (Fig. 1). Patients who had stayed for at least one night in either hospital and had complete data were included for the analysis. Patients who had not had a surgical indication and/or who had confirmed microbiology culture test reports for a bacterial infection were excluded from further analysis.

Statistical analysis

Excel and STATA software version 15.0 (Stata Corp., College Station, Texas, USA) were utilized for the statistical analysis. For categorical variables, frequency and percentages were calculated. Sum, mean, and standard deviation were calculated for continuous values. The independent sample t test was used to compare continuous variables and chi-square tests to compare categorical variables. The p value < 0.001 was considered significant. The low p value was selected as a large number of variables were analyzed which might lead to a large risk of type I errors (false-positive results).

Results

Antibiotic prescribing at the department level

Among 12,992 enrolled inpatients, 6315 were admitted at the rural (TH) and 6677 at the urban hospital (NTH, Fig. 1). Of these, 12,434 inpatients fulfilled inclusion criteria and were included in the study: 6171 (98%) patients at the TH and 6263 (94%) at the NTH. Antibiotics were prescribed to 88% inpatients in the TH and 86% in the NTH. The length of hospital stay ranged between 1 and 129 days at TH, and 1 and 56 days at the NTH; antibiotic treatment ranged between 1 and 110 days, and 1 and 44 days at the TH and NTH, respectively (Table 1). Both the average length of hospital stay (9.9 vs 4.6 days) and the average length of antibiotic treatment (9.5 vs 4.4 days) were significantly higher in the TH compared to the NTH.
Table 1
Inpatients’ characteristics at surgery departments of the TH and NTH in Madhya Pradesh, India
 
All patients
UUTSI
LUTSI
RASI
EASI
TH, N = 6171
NTH, N = 6263
TH, N = 284
NTH, N = 741
TH, N = 748
NTH, N = 824
TH, N = 1394
NTH, N = 748
TH, N = 482
NTH, N = 763
n (%)
n (%)
n (%)
n (%)
n (%)
n (%)
n (%)
n (%)
n (%)
n (%)
Age in years
 0–17
677 (11) a
377 (6)
21 (7)
36 (5)
45 (6) a
15 (2)
139 (10) a
26 (3)
72 (15)
91 (12)
 18–39
2018 (33)
2757 (44) a
159 (56)
425 (57)
69 (9)
119 (14)
320 (23)
281 (38) a
239 (50)
419 (55)
 40–59
1773 (29)
1689 (27)
78 (27)
197 (27)
150 (20)
148 (18)
453 (32)
222 (30)
108 (22)
188 (25)
 ≥ 60
1703 (28) a
1440 (23)
26 (9)
83 (11)
484 (65)
542 (66)
482 (35)
219 (29)
63 (13)
65 (8)
Male
4601 (75) a
4384 (70)
218 (77)
546 (74)
719 (96)
812 (99)
1182 (85) a
532 (71)
347 (72)
610 (80)
Female
1570 (25)
1879 (30) a
66 (23)
195 (26)
29 (4)
12 (1)
212 (15)
216 (29) a
135 (28)
153 (20)
Patients prescribed AB
5430 (88)
5402 (86)
251 (88)
624 (84)
748 (100)
823 (100)
1393 (100) a
628 (84)
482 (100) a
719 (94)
Total number of AB prescriptions (Np)
12,213
9598
563
1055
1624
1453
2767
1240
1435
1679
Prescriptions adherent to WHOLEM, Np (percentage of total nr. of prescriptions)
8039 (66) a
4019 (42)
309 (55) a
346 (33)
753 (46) a
346 (24)
1736 (63) a
510 (41)
1054 (73) a
790 (47)
Prescriptions adherent to NLEMI, Np (percentage of total nr. of prescriptions)
9119 (75) a
5487 (57)
342 (61)
592 (56)
880 (54) a
592 (41)
2025 (73) a
734 (59)
1173 (82) a
984 (59)
Average length of hospital stay, days [SD]
9.9 [10.0] a
4.6 [3.9]
9.1 [7.8] a
3.8 [3.2]
13.0 [11.3] a
5.0 [3.2]
9.8 [7.2] a
5.1 [4.0]
11.1 [9.5] a
6.3 [5.3]
Average length of AB treatment, days [SD]
9.5 [7.6] a
4.4 [3.2]
8.6 [6.9] a
3.6 [2.6]
11.5 [9.0] a
4.9 [3.0]
7.8 [5.3] a
4.4 [3.4]
9.0 [7.4] a
5.5 [4.0]
AB prescribed for 1 day
36 (1)
221 (7)
7 (2)
96 (13)
6 (1)
44 (5)
14 (1)
41 (5)
9 (2)
40 (5)
DDD/100 patient days
72.5
110.5 a
89.5
112.3 a
84.6
102.1 a
78.3
116.1 a
74.9
106.0 a
Total nr. of AB doses administered
65,288
28,600
2759
2950
9415
4733
13,890
4060
6270
7980
Total nr. of AB doses prescribed using generic names
16,322 (25) a
1716 (6)
607 (22) a
118 (4)
2542 (27) a
142 (3)
4584 (33) a
203 (5)
1693 (27) a
399 (5)
Total nr. of AB doses administered parenterally
34,613 (53)
19,639 (79) a
1335 (41)
2245 (76) a
3672 (39)
2603 (55) a
8195 (59)
3370 (83) a
4582 (75)
7339 (92) a
Variables are presented either with percentages or standard deviations in parenthesis. Percentages were rounded off to integers, and standard deviations were rounded off to one decimal. Percentages are presented in parenthesis, and standard deviations in square brackets. Abbreviations: AB antibiotic, DDD defined daily dose, EASI emergency abdominal surgery indications, Np total number of antibiotic prescriptions, nr. number, LUTSI lower urinary tract surgery indications, NLEMI National List of Essential Medicines of India, NTH non-teaching hospital, RASI routine abdominal surgery indications, SD standard deviation, TH teaching hospital, UUTSI upper urinary tract surgery indications, WHOLEM WHO List of Essential Medicines
a Significantly larger p-values
In the NTH, the DDDs/100 patient days was significantly higher (110.5 vs 72.5, p < 0.001) and a larger proportion of the antibiotics were administered by parenteral route (79% vs 53%, p < 0.001) than in the TH. Antibiotics were advised after hospital discharge to 1349 patients 1359 (22%) in the TH and to 3136 (50%) patients in the NTH. Overall, significantly larger proportion of antibiotics were prescribed by generic names (25% vs 6%, p < 0.001) and prescriptions were more adherent to WHOLEM (66% vs 42%, p < 0.001) and NLEMI (75% vs 57%, p < 0.001) in the TH compared to NTH (Table 1).

Diagnosis panorama

Gastrointestinal diseases (ICD-10: K, 33%), urogenital diseases (ICD-10: N, 28%), and skin diseases (ICD-10: L, 9%) were the most common diagnoses groups, sorted by the first level of ICD-10 classification system, at surgery departments of the TH (n = 12,434) (World Health Organization 2010). Whereas in the NTH, urogenital diseases (ICD-10: N, 38%), gastrointestinal diseases (ICD-10: K, 26 %), and symptoms without specific diagnoses (ICD-10: R, 12 %) were most commonly recorded.
Of the total 12,434 inpatients, 150 patients had either microbiology reports to confirm the presence of a bacterial infection or a clear clinical indication for the presence of bacterial infection. A total of 6300 inpatients were discharged from the departments without undergoing any surgery leaving 5984 inpatients for further detailed analysis (Fig. 1).
These 5984 inpatients were divided into four diagnoses groups as described in the “Methods” section (UUTSI, LUTSI, RASI, and EASI). Overall, ventral or inguinal hernias (n = 1277), benign prostate hyperplasia (n = 1080), kidney or ureter stones (n = 1014), appendicitis (n = 727), and intestinal obstructions (n = 334) were the most common diagnoses. Table 2 presents the list of most common diagnoses among the selected inpatients.
Table 2
Classification of surgery inpatients in four selected diagnoses groups, based on their diagnoses
Diagnosis groups (ICD-10 codes)
TH, n = 2908 (100)
NTH, n = 3076 (100)
n (%) [%]
n (%) [%]
Upper urinary tract surgery indications (UUTSI)
284 (10) [100]
741(24) [100] a
 Kidney/ureter calculi (N20)
280 [99]
734 [99] a
 Other
4 [32]
7 [1]
Lower urinary tract surgery indications (LUTSI)
748 (26) [100]
824 (27) [100]
 Benign prostate hyperplasia (N40)
522 [70]
558 [68]
 Urethral/bladder calculi (N21)
89 [12]
142 [17] a
 Urethral stricture (N35)
85 [11]
66 [8]
 Prostate cancer (C61)
29 [4]
30 [4]
 Bladder cancer (C67)
10 [1]
10 [1]
 Urethral disease* (N36)
9 [1]
10 [1]
 Other
4 [< 1]
8 [< 1]
Routine abdominal surgery indications (RASI)
1394 (48) [100] a
748 (24) [100]
 Hernia (K40-K46)
965 [69] a
312 [42]
 Other gastric/duodenal disease (K31)
113 [8]
151 [20]
 Biliary calculi (K80)
73 [5]
110 [15]
 Anal fissure/fistula (K60)
103 [7] a
30 [4]
 Malignancy in GI-tract (C15-C26)
78 [6]
51 [7]
 Cholecystitis (K81)
30 [2]
43 [6]
 Anal abscess (K61)
10 [< 1]
28 [4]
 Other disease in anal region** (K62)
10 [< 1]
8 [1]
 Colon polyposis (K63.2)
9 [< 1]
5 [< 1]
 Other
3 [< 1]
10 [< 1]
Emergency abdominal surgery indications (EASI)
482 (17) [100]
763 (25) [100] a
 Appendicitis (K35-K37)
268 [56]
459 [60] a
 Intestinal obstruction (K56)
132 [27]
202 [27]
 Peritonitis (K56)
80 [17]
99 [13]
 Other
2 [< 1]
3 [< 1]
Numbers of patients with percentages rounded off to the nearest whole number. Abbreviations: TH teaching hospital, ns p value value not significant, NTH non-teaching hospital
*Urethral disease includes fistulas, diverticulosis, carbuncles, and prolepses of the urethra
**Disease in the anal/rectal region includes polyps, stenosis, wounds, bleedings, and prolapses in the anal/rectal region
a Significantly larger p-values

Antibiotic prescribing in four selected surgical diagnoses groups

The average length of hospital stay was significantly longer in the TH (9.1 to 13.0 days) across all selected diagnoses groups compared to the NTH (3.8 to 6.3 days) (Table 1). The inpatients in the TH also had a significantly longer duration of antibiotic treatment in all diagnoses groups with an average between 7.8 and 11.5 days, while in the NTH, it ranged between 3.6 and 5.5 days. Exclusive PAP was not observed in any of the cases in both hospitals. However, in the TH and NTH, 1% and 7% of inpatients, respectively, were prescribed antibiotics for 1 day. A significantly higher proportion of inpatients in both the RASI (100% vs 84%) and the EASI groups (100% vs 94%) were prescribed antibiotic treatment in the TH compared to the NTH, respectively. However, there was no significant difference between the proportions of patients being prescribed antibiotics for the UUTSI and the LUTSI. In general, the prescriptions from the TH adhered significantly more to the available prescribing guidelines (NLEMI and WHOELM) in all diagnosis groups compared to the NTH (Table 1).
Fixed-dose combinations (FDCs) of antibiotics and third-generation cephalosporins were prescribed to a larger extent in all diagnosis groups in the NTH (Table 3). With regard to the proportion of prescribed antibiotics for the selected diagnoses groups, quinolones appeared to be the highest prescribed therapeutic sub-group in the UUTSI and LUTSI groups in both hospitals (Table 3).With respect to the number of patients, most of the inpatients in the LUTSI group received quinolones (TH 70% and NTH 61%) and aminoglycosides (TH 37% and NTH 50%). In RASI group in the TH, most of the inpatients received aminoglycosides (32%), other beta-lactam antibiotics (cephalosporins, 29%), and imidazole derivatives (29%), whereas in the NTH, other beta-lactam antibiotics (cephalosporins, 39%) and FCDs (36%) were the most prescribed. The highest proportion of patients in the EASI received imidazole derivatives (TH 75% and 56% NTH), FDCs (NTH 48%), and quinolones (TH 48%; Fig. 2).
Table 3
Antibiotic prescribing patterns in four surgical diagnoses groups at surgery departments of the TH and NTH
 
UUTSI
LUTSI
RASI
EASI
TH, N = 563
NTH, N = 1055
TH, N = 1624
NTH, N = 1453
TH, N = 2767
NTH, N = 1240
TH, N = 1435
NTH, N = 1679
n (%)
n (%)
n (%)
n (%)
n (%)
n (%)
n (%)
n (%)
Tetracyclines (J01A), n (% of N)
32 (6)
2 (< 1)
50 (3)
0
233 (8)
6 (< 1)
98 (7)
2 (< 1)
Amphenicols (J01B), n (% of N)
0
0
0
0
0
0
1
0
Penicillins (J01C), n (% of N)
17 (3)
42 (4)
77 (5)
80 (6)
219 (8)
80 (6)
131 (9)
147 (9)
 Penicillins with extended spectrum (J01CA), x (% of n)
3 (18)
2 (5)
5 (6)
4 (5)
21 (10)
16 (20)
0
10 (7)
 Penicillins combinations including enzyme inhibitors (J01CR), x (% of n)
14 (82)
40 (95)
72 (94)
76 (95)
198 (90)
64 (80)
131 (100)
137 (93)
Other beta-lactam antibiotics (J01D), n (% of N)
70 (12)
239 (23)
220 (14)
191 (13)
535 (19)
332 (27)
218 (15)
296 (18)
 First-generation cephalosporins J01DB, x (% of n)
19 (27)
7 (3)
49 (22)
1 (< 1)
149 (28)
17 (5)
50 (23)
11 (4)
 Second-generation cephalosporins J01 DC, x (% of n)
0
9 (4)
13 (6)
24 (13)
23 (4)
41 (12)
5 (2)
29 (10)
 Third-generation cephalosporins J01DD, x (% of n)
51 (72)
222 (93)
158 (72)
166 (87)
363 (68)
272 (82)
162 (74)
254 (86)
 Fourth-generation cephalosporins J01DE, x (% of n)
0
1 (< 1)
0
0
0
1 (< 1)
0
0
 Carbapenems J01DH, x (% of n)
0
0
0
0
0
1 (< 1)
1 (< 1)
2 (< 1)
Sulfonamids and trimethoprim (J01E), n (% of N)
11 (2)
0
85 (5)
0
100 (4)
0
16 (1)
0
Macrolids and lincosamids (J01F), n (% of N)
38 (7)
0
180 (11)
2 (< 1)
405 (15)
3 (< 1)
94 (7)
8 (< 1)
 Macrolids (J01FA), x (% of n)
0
0
4 (2)
0
3 (< 1)
0
1 (1)
0
 Lincosamids (J01FF), x (% of n)
38 (100)
0
176 (98)
2 (100)
402 (99)
3
93 (99)
8 (100)
Aminoglycosides (J01G), n (% of N)
76 (13)
269 (26)
328 (20)
449 (31)
486 (18)
250 (20)
189 (13)
225(13)
Quinolones (J01 M), n (% of N)
216 (38)
281 (27)
609 (38)
543 (37)
315 (11)
114 (9)
263 (18)
145 (9)
Fixed-dose combinations (J01R), n (% of N)
3 (1)
160 (15)
22 (1)
155 (11)
37 (1)
298 (24)
17 (1)
399 (24)
 Quinolones and imidazole derivatives*, x (% of n)
0
2 (1)
0
17 (11)
0
26 (9)
0
22 (6)
 Cephalosporins and enzyme inhibitors, x (% of n)
3 (100)
158 (99)
22 (100)
138 (89)
37
272 (91)
17 (100)
377 (94)
Other antibiotics (J01X), n (% of N)
100 (18)
62 (6)
53 (3)
33 (2)
437 (16)
157 (13)
408 (28)
457 (27)
 Imidazole derivatives (J01XD)**, x (% of n)
100 (100)
62 (97)
53 (100)
31 (94)
437 (100)
157 (100)
408 (100)
453 (99)
 Other antibiotics (J01XX), x (% of n)
0
2 (3)
0
2 (6)
0
0
0
4 (1)
EASI emergency abdominal surgery indications, LUTSI lower urinary tract surgery indications, N total number of prescriptions in the diagnosis group, n number of prescriptions for the third-level ATC pharmacological sub-group, RASI routine abdominal surgery indications, UUTSI upper urinary tract surgery indications, x number of prescriptions for the fourth-level ATC pharmacological sub-group. Percentages were rounded and presented in parenthesis
*Fixed-dose combinations that were not assigned by WHOCC, a fourth level ATC-code
**The imidazole derivate group also included oral metronidazole categorized as P01AB01
The overall mortality was significantly higher in the TH than in the NTH (p < 0.001). In the TH, 39 patients died (1%), of those, 8 had perforation peritonitis, 6 had an intestinal obstruction, 6 had cancers, and 4 were burn cases, while in NTH, 6 inpatients died (0.2%) who had diagnoses other than selected groups.

Discussion

To the best of our knowledge, this is the first study that presents the antibiotic prescribing patterns among inpatients having the surgical diagnosis from two Indian private sector hospitals. Irrespective of the presence or absence of infectious indication, almost all inpatients across the four most common surgical diagnoses groups (UUTSI, LUTSI, RASI, and EASI) were prescribed antibiotics. The universal recommendation to administer a single dose of antibiotic preoperatively, as prophylaxis, was not followed in any patents in both study settings. High proportions of broad-spectrum antibiotics were prescribed for a long duration in the settings. Antibiotics were prescribed with higher DDDs/100 patient days in the NTH than in the TH.
Nearly 90% of all inpatients at both settings were prescribed antibiotics during their hospital stay. The proportion of patients who were prescribed antibiotics in this study was higher than shown in a 5-month hospital-level study (79–82%) conducted previously at the study settings (Sharma et al. 2012). Thus, the result of the present study endorses the results of the global antibiotic consumption data from 2000 to 2010, which states a rapid increase in per capita antibiotic use in India (Van Boeckel et al. 2014). Escalation of infectious diseases and the use of antibiotics as preventive medicine were considered as the main reasons for this increase (Van Boeckel et al. 2014).
The diagnostic tools, such as microbiology culture and susceptibility test reports justify the antibiotic prescribing and suggest the effective class of antibiotics to prescribe. Although empirical therapy often needs to be started before the diagnostic results are obtained, narrowing of the antibiotic therapy based on the lab reports helps to slow down the development of ABR. Despite the presence of microbiology facilities in proximity in both hospitals, microbiology tests were not advised frequently in the study hospitals. Most of the antibiotic prescriptions were managed empirically throughout the hospital stay. The results highlight that the microbiology lab facilities were underused in the study settings, therefore resulting in a continuation of antibiotic treatment. In the four selected diagnoses groups, none of the patients had any microbiologically confirmed bacterial infection; therefore, they ought not to receive any antibiotic treatment but only a recommended dose of PAP.
Antibiotic prophylaxis is defined as the administration of a single dose of the effective antimicrobial agent prior to the exposure with possible contamination, i.e., surgery to reduce the risk of SSI (World Health Organization 2016). This single dose of antibiotic is recommended to be given 120 to 60 min before surgical incision. The most recent guidelines of the Centers for Disease Control and Prevention (CDC) restricts any additional prophylactic antibiotics after the completion of the clean and clean-contaminated surgical procedures (Crader and Bhimji 2018). Despite these recommendations, antibiotics were prescribed for a longer time period as a treatment regime to a majority of the inpatients in both settings.
Cefazolin (J01DB04), a first-generation cephalosporin, provides adequate coverage against most of the organisms causing postoperative infections; it causes minimal allergic reactions and side effects, achieves adequate tissue levels, and is relatively less expensive. The presence of these benefits makes cefazolin the most appropriate PAP agent for the majority of the surgical procedures (World Health Organization 2016). Overall, cefazolin was prescribed only in ≤ 28% cases in the TH and even significantly less in the NTH (≤ 5%, p < 0.05). In the EASI group, imidazole derivatives were most commonly prescribed in both hospitals. In the RASI group, aminoglycosides in the TH and FDCs of third-generation cephalosporins in the NTH were commonly prescribed instead of cefazolin (World Health Organization 2016). In both the UUTSI and the LUTSI groups, quinolones were the most commonly prescribed in both hospitals (Table 3). The administration of quinolones as prophylaxis is recommended for specific urogynecology surgical procedures that were not performed frequently in the study settings (Bulletins--Gynecology 2009). Therefore, the classes of antibiotics prescribed in the selected diagnoses groups could not be considered as optimal PAP treatment as per international guidelines and the prescription pattern might need a reconsideration.
An average antibiotic period for all four groups was almost equal to the average hospitalization duration for most of the patients in both hospitals specifically in the TH (Table 1). The hospital stay and duration of antibiotic treatment in the TH were significantly longer compared to the NTH. This can be due to the free service provision, including medicines and the diagnostics, to all patients in the TH. On the contrary in the NTH, patients had to pay out-of-pocket for provided services and medicines. Spending money out-of-pocket might be shorter length of stay and shorter duration of prescription in the NTH, the inpatients at the NTH. Although, prescribing antibiotics for shorter or longer time periods than recommended, is considered inappropriate being a trigger for the development and spread of ABR.
Similar to our study results, an Iranian study showed antibiotic treatment in 83% of cases though it was indicated only in 37% cases (Vessal et al. 2011). The duration of antibiotic administration was extended beyond the prophylactic period in a questionnaire survey for colorectal surgery at 721 Japanese institutions and analysis of 34133 medical records of patients undergoing 5 major surgical procedures in the USA (Kobayashi et al. 2011; Bratzler et al. 2005). Unindicated prescribing of antibiotics and its extension for long durations to prevent SSIs in high-risk patient groups is a global problem and a major contributing factor for the development of ABR (Bulletins--Gynecology 2009; Vessal et al. 2011). Dissemination of knowledge into practice is a challenging and long-term process (Vessal et al. 2011; Kobayashi et al. 2011; Bratzler et al. 2005). It also plays a pivotal role in increasing the cost of treatment, imposing a high economic burden on the country, patients, and healthcare systems, and increases resource constraints specifically in countries like India.
Our study also highlights the selection and prescribing of broad-spectrum antibiotics such as fluoroquinolones, FDCs of third-generation cephalosporins, imidazole derivatives, and aminoglycosides throughout the selected diagnoses groups regardless of the surgery indications. The recommended narrow-spectrum antibiotics such as penicillins were used to a limited extent in both hospitals which shows a clear deviation from the available international guidelines provided by the CDC (Kobayashi et al. 2011). The inpatients at the TH were more likely to receive tetracycline, lincosamides, quinolones, and imidazole derivatives, while inpatients at the NTH were more often prescribed FDCs of cephalosporins. Most of the prescribed FDCs of a cephalosporin and a beta-lactamase inhibitor (16–47% in the NTH) across all four diagnosis groups have no underlying scientific justification (Table 3). These combinations are justified only in case of ESBL-producing strains of E.coli and Klebsiella. This practice not only increases the treatment cost but also is a contributor to the development of ABR. In a single-center study in Andhra Pradesh, India, Khade et al. observed high use of fluoroquinolones (28%), cephalosporins (18%), aminoglycosides (14%), and imidazole derivatives (22%) in a surgery department (Khade et al. 2013). However, high prescribing of the FDCs in our settings is a point of concern.
Local prescribing guidelines are adjusted to the local disease panorama and resistance patterns; therefore, its implementation can improve antibiotic prescribing practices and minimize the development of ABR (Bulletins--Gynecology 2009; Vessal et al. 2011; CDC 2018; Khade et al. 2013; Parulekar et al. 2009). There is an urgent need to develop and implement the local prescribing guidelines, and prescription monitoring for justified use of antibiotics. Our results also recommend to explore the underlying reasons for such prescribing patterns using both qualitative and quantitative approaches among the prescribers, policymakers, community, and dispensers.
Other highlights of the study are significantly less prescribing of antibiotics by generic names and a higher proportion of antibiotics prescribed via the parenteral route of administration with higher defined daily doses (in DDDs/100 patient days) in the NTH compared to the TH; across all four diagnosis groups. The generic medicines are bioequivalent to the branded medicines, are cost-effective compared to branded medicines, and promise compliance with the prescription (Sharma et al. 2012). At the TH, the purchase and supply of the medicines are managed by the hospital management, which is obliged to maintain a good quality of medicines with the lowest possible costs. This might be the reason for higher generic name prescribing at the TH. Moreover, the prescribers at the NTH were exposed to the sales representatives of pharmaceutical companies but not at the TH. This exposure might have resulted in higher pressure on the prescribers of the NTH for prescribing medicines by brand names (Blumenthal 2004). Other possible explanations for a more conservative approach for the DDDs/100 patient days in the TH can be the updated knowledge about the severity of the problem of ABR through continued medical education programs. These programs are regularly conducted as a part of the curriculum at the TH, but not at the NTH. A strong customer-supplier-oriented relationship between the patient and the prescriber is developed when the patients pay out-of-pocket for the healthcare, as in the NTH. The patients in such situations demand quick relief through antibiotics, and prescribers aim to satisfy the patients’ demand. This was observed previously in studies from India and Malaysia (Kotwani et al. 2010; Ab Rahman et al. 2016). The assessment of demand-supply relation was not conducted in the present study being beyond the aim but could be a part of the future study.

Strengths and limitations

A major strength of this study is the manual prospective data collection method among a large group of patients during 3 years’ time period in two private hospitals in India. In the present study, demographic characteristics were not considered as the selection parameter. This allowed the inclusion of a wide cross-section of the inpatients. The study provided a diagnose-specific detailed record of prescribing antibiotics in surgery departments in two private sector hospitals (a teaching and a non-teaching). The study population and their disease panorama were comparable with populations from other similar settings and may serve as representative of average Indian surgery departments. The data was collected for a long time period which helps to overcome the confounding factors caused by seasonal changes. In addition, this study gives an overview of antibiotic use and fills up the surveillance knowledge gap necessary to take further steps to combat antibiotic resistance. It is also in line with the Global Action Plan to Combat Antimicrobial Resistance.
Several limitations of this study need to be acknowledged. Firstly, the absence of computerized record systems in hospitals and of personal identification numbers, untrained staff, and high staff turnover make a detailed study like this time-consuming and onerous and delay the analysis. However, the use of manpower is the only option to conduct such detailed studies at resource-constrained settings but at the same time leads to a more accurate description of the prescribing patterns. The authors are aware that extensive manual checking and adding the ICD codes and ATCs for the new FDCs to the data have prolonged the analysis and delayed the presentation. Although, the data represented in this paper is from 2008 till 2011, however, similar trend for antibiotic use has been predicted through extrapolation in HISTI model by Tamhankar et al. (Tamhankar et al. 2018) which increases the validity of the result of our study also in present context. Moreover, the ATC codes of the new FDCs assigned by the authors will serve as a reference point for other studies to be published in the future. The situation we want to emphasize here is the high prescribing of FDCs, broad-spectrum antibiotics, and prescribing these for an incorrect indication for inappropriate time. Also, the lack of national PAP guidelines and local prescribing guidelines in hospitals is still present. We, therefore, believe that the results of the current study, as well as upcoming publications from these settings, will be a starting point for the discussion on the necessity of local prescribing guidelines and a driving force for action.
Finally, the diagnoses were not validated externally, as this was not the aim of the study. The detailed information regarding the surgeries or risk factors for surgical patients was not collected in this study. The results of this study demonstrate the need for context-specific guidelines to regulate the use of antibiotics during surgical procedures:
  • Large patient group with no exclusion due to demographic variables
  • Disease panorama similar to other Indian settings
  • Data collection during a long time period decrease confounding by seasonal change
  • No data on actual surgeries collected
  • No data on antibiotic resistance patterns of pathogens in the setting

Conclusion

This study highlights an extensive prescribing of antibiotics, specifically broad spectrum antibiotics including FDCs across the departments and in selected most common surgical diagnosis groups irrespective of any indication of an infection. The universal recommendations of preoperative use of antibiotics were not followed in majority of the cases in both hospitals. The study also highlights underuse of the microbiology diagnostic tools and extended empirical prescribing. Thus, the results clearly point towards an urgent need to develop and implement locally adjusted diagnose-specific antibiotic prescribing guidelines and regular monitoring thereafter at the settings. The results of the present study are expected to have a significant impact on the prescribers, to initiate the development of local prescribing guidelines.

Future implications

The result of the study could be provided as feedback to the prescribers to encourage them to utilize the diagnostic facilities. This will help to conduct studies to describe the ABR pattern in pathogens in the region and then to evaluate the rationality of selection of prescribed antibiotics in order to create locally adjusted diagnosis-specific antibiotic prescribing guidelines. The ATC codes of the new FDCs assigned by the authors could be used as a reference for other studies for better comparison of the results. Qualitative studies are needed to understand the factors contributing to the present antibiotic prescribing patterns. In parallel, several educational interventions targeting community about not demanding antibiotics and not self–medicating with antibiotics are suggested.

Acknowledgements

The authors extend thanks to the nurses of surgery departments for their invaluable contribution during the data collection. We acknowledge the management of both hospitals and Dr. V. K. Mahadik (Medical Director of R. D. Gardi Medical College, Ujjain) for their support and patronage during the study period.
The ethics committee of Ruxmaniben Deepchand Gardi Medical College, Ujjain, approved the study with approval number: 41/2007 and 114/2010. This was an observational study where the data collection did not interfere in the patients receiving the treatment. All patients were given unique codes locally to maintain confidentiality. The data were collected at the individual level for all inpatients and were linked to each patient with the assigned unique codes. Moreover, the analysis was performed in groups using these unique codes. No exclusions were made on the basis of age, sex, or other demographic criteria.
Not applicable

Competing interests

The authors declare that they have no competing interests
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
Zurück zum Zitat Ab Rahman N, Teng CL, Sivasampu S. Antibiotic prescribing in public and private practice: a cross-sectional study in primary care clinics in Malaysia. BMC Infect Dis. 2016;16:208.CrossRef Ab Rahman N, Teng CL, Sivasampu S. Antibiotic prescribing in public and private practice: a cross-sectional study in primary care clinics in Malaysia. BMC Infect Dis. 2016;16:208.CrossRef
Zurück zum Zitat Alp E, Elmali F, Ersoy S, Kucuk C, Doganay M. Incidence and risk factors of surgical site infection in general surgery in a developing country. Surg Today. 2014;44(4):685–9.CrossRef Alp E, Elmali F, Ersoy S, Kucuk C, Doganay M. Incidence and risk factors of surgical site infection in general surgery in a developing country. Surg Today. 2014;44(4):685–9.CrossRef
Zurück zum Zitat Alvarez-Uria G, Zachariah S, Thomas D. High prescription of antimicrobials in a rural district hospital in India. Pharm Pract (Granada). 2014;12(2):384.CrossRef Alvarez-Uria G, Zachariah S, Thomas D. High prescription of antimicrobials in a rural district hospital in India. Pharm Pract (Granada). 2014;12(2):384.CrossRef
Zurück zum Zitat Blumenthal D. Doctors and drug companies. N Engl J Med. 2004;351(18):1885–90.CrossRef Blumenthal D. Doctors and drug companies. N Engl J Med. 2004;351(18):1885–90.CrossRef
Zurück zum Zitat Bou-Antoun S, Costelloe C, Honeyford K, Mazidi M, Hayhoe BWJ, Holmes A, et al. Age-related decline in antibiotic prescribing for uncomplicated respiratory tract infections in primary care in England following the introduction of a national financial incentive (the Quality Premium) for health commissioners to reduce the use of antibiotics in the community: an interrupted time series analysis. J Antimicrob Chemother. 2018;73(10):2883–92.CrossRef Bou-Antoun S, Costelloe C, Honeyford K, Mazidi M, Hayhoe BWJ, Holmes A, et al. Age-related decline in antibiotic prescribing for uncomplicated respiratory tract infections in primary care in England following the introduction of a national financial incentive (the Quality Premium) for health commissioners to reduce the use of antibiotics in the community: an interrupted time series analysis. J Antimicrob Chemother. 2018;73(10):2883–92.CrossRef
Zurück zum Zitat Bratzler DW, Houck PM, Richards C, Steele L, Dellinger EP, Fry DE, et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg. 2005;140(2):174–82.CrossRef Bratzler DW, Houck PM, Richards C, Steele L, Dellinger EP, Fry DE, et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg. 2005;140(2):174–82.CrossRef
Zurück zum Zitat Bulletins--Gynecology ACP. ACOG practice bulletin No. 104: antibiotic prophylaxis for gynecologic procedures. Obstet Gynecol. 2009;113(5):1180–9.CrossRef Bulletins--Gynecology ACP. ACOG practice bulletin No. 104: antibiotic prophylaxis for gynecologic procedures. Obstet Gynecol. 2009;113(5):1180–9.CrossRef
Zurück zum Zitat CDC. Surgical Site Infection (SSI) Event. 2018. CDC. Surgical Site Infection (SSI) Event. 2018.
Zurück zum Zitat Census of India. Size, growth rate and distribution of population; 2011. Census of India. Size, growth rate and distribution of population; 2011.
Zurück zum Zitat Chandy SJ, Naik GS, Balaji V, Jeyaseelan V, Thomas K, Lundborg CS. High-cost burden and health consequences of antibiotic resistance: the price to pay. J Infect Dev Ctries. 2014;8(9):1096–102.CrossRef Chandy SJ, Naik GS, Balaji V, Jeyaseelan V, Thomas K, Lundborg CS. High-cost burden and health consequences of antibiotic resistance: the price to pay. J Infect Dev Ctries. 2014;8(9):1096–102.CrossRef
Zurück zum Zitat Crader MF, Bhimji SS. Preoperative Antibiotic Prophylaxis. Treasure Island: StatPearls; 2018. Crader MF, Bhimji SS. Preoperative Antibiotic Prophylaxis. Treasure Island: StatPearls; 2018.
Zurück zum Zitat Deshpande K, RaviShankar DV, Lonnroth K, Mahadik VK, Chandorkar RK. Spatial pattern of private health care provision in Ujjain, India: a provider survey processed and analysed with a Geographical Information System. Health Policy. 2004;68(2):211–22.CrossRef Deshpande K, RaviShankar DV, Lonnroth K, Mahadik VK, Chandorkar RK. Spatial pattern of private health care provision in Ujjain, India: a provider survey processed and analysed with a Geographical Information System. Health Policy. 2004;68(2):211–22.CrossRef
Zurück zum Zitat Gagliotti C, Balode A, Baquero F, Degener J, Grundmann H, Gur D, et al. Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill. 2011;16(11). Gagliotti C, Balode A, Baquero F, Degener J, Grundmann H, Gur D, et al. Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill. 2011;16(11).
Zurück zum Zitat Ganguly NK. Situation analysis. Antibiotic use and resistance in India: The center for disease dynamics, economics & policy; 2011. Ganguly NK. Situation analysis. Antibiotic use and resistance in India: The center for disease dynamics, economics & policy; 2011.
Zurück zum Zitat Gould IM. Antibiotic policies and control of resistance. Curr Opin Infect Dis. 2002;15(4):395–400.CrossRef Gould IM. Antibiotic policies and control of resistance. Curr Opin Infect Dis. 2002;15(4):395–400.CrossRef
Zurück zum Zitat Hawkey PM. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect. 2008;14(Suppl 1):159–65.CrossRef Hawkey PM. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect. 2008;14(Suppl 1):159–65.CrossRef
Zurück zum Zitat Hohmann C, Eickhoff C, Radziwill R, Schulz M. Adherence to guidelines for antibiotic prophylaxis in surgery patients in German hospitals: a multicentre evaluation involving pharmacy interns. Infection. 2012;40(2):131–7.CrossRef Hohmann C, Eickhoff C, Radziwill R, Schulz M. Adherence to guidelines for antibiotic prophylaxis in surgery patients in German hospitals: a multicentre evaluation involving pharmacy interns. Infection. 2012;40(2):131–7.CrossRef
Zurück zum Zitat Khade A, Bashir M, Sheethal A. Prescription pattern in the department of surgery in a tribal district hospital of Andhra Pradesh, India. Ann Med Health Sci Res. 2013;3(3):438–41.CrossRef Khade A, Bashir M, Sheethal A. Prescription pattern in the department of surgery in a tribal district hospital of Andhra Pradesh, India. Ann Med Health Sci Res. 2013;3(3):438–41.CrossRef
Zurück zum Zitat Kobayashi M, Takesue Y, Kitagawa Y, Kusunoki M, Sumiyama Y. Antimicrobial prophylaxis and colon preparation for colorectal surgery: Results of a questionnaire survey of 721 certified institutions in Japan. Surg Today. 2011;41(10):1363–9.CrossRef Kobayashi M, Takesue Y, Kitagawa Y, Kusunoki M, Sumiyama Y. Antimicrobial prophylaxis and colon preparation for colorectal surgery: Results of a questionnaire survey of 721 certified institutions in Japan. Surg Today. 2011;41(10):1363–9.CrossRef
Zurück zum Zitat Kotwani A, Wattal C, Katewa S, Joshi PC, Holloway K. Factors influencing primary care physicians to prescribe antibiotics in Delhi India. Fam Pract. 2010;27(6):684–90.CrossRef Kotwani A, Wattal C, Katewa S, Joshi PC, Holloway K. Factors influencing primary care physicians to prescribe antibiotics in Delhi India. Fam Pract. 2010;27(6):684–90.CrossRef
Zurück zum Zitat Lindsjo C, Sharma M, Mahadik VK, Sharma S, Stalsby Lundborg C, Pathak A. Surgical site infections, occurrence, and risk factors, before and after an alcohol-based handrub intervention in a general surgical department in a rural hospital in Ujjain, India. Am J Infect Control. 2015;43(11):1184–9.CrossRef Lindsjo C, Sharma M, Mahadik VK, Sharma S, Stalsby Lundborg C, Pathak A. Surgical site infections, occurrence, and risk factors, before and after an alcohol-based handrub intervention in a general surgical department in a rural hospital in Ujjain, India. Am J Infect Control. 2015;43(11):1184–9.CrossRef
Zurück zum Zitat P C. Healthcare in India: Features of one of the most privatised systems in the world; 2009. P C. Healthcare in India: Features of one of the most privatised systems in the world; 2009.
Zurück zum Zitat Parulekar L, Soman R, Singhal T, Rodrigues C, Dastur FD, Mehta A. How good is compliance with surgical antibiotic prophylaxis guidelines in a tertiary care private hospital in India? A prospective study. Indian J Surg. 2009;71(1):15–8.CrossRef Parulekar L, Soman R, Singhal T, Rodrigues C, Dastur FD, Mehta A. How good is compliance with surgical antibiotic prophylaxis guidelines in a tertiary care private hospital in India? A prospective study. Indian J Surg. 2009;71(1):15–8.CrossRef
Zurück zum Zitat Pathak A, Marothi Y, Kekre V, Mahadik K, Macaden R, Lundborg CS. High prevalence of extended-spectrum beta-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India. Infect Drug Resist. 2012;5:65–73.CrossRef Pathak A, Marothi Y, Kekre V, Mahadik K, Macaden R, Lundborg CS. High prevalence of extended-spectrum beta-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India. Infect Drug Resist. 2012;5:65–73.CrossRef
Zurück zum Zitat Pathak A, Saliba EA, Sharma S, Mahadik VK, Shah H, Lundborg CS. Incidence and factors associated with surgical site infections in a teaching hospital in Ujjain, India. Am J Infect Control. 2014;42(1):e11–5.CrossRef Pathak A, Saliba EA, Sharma S, Mahadik VK, Shah H, Lundborg CS. Incidence and factors associated with surgical site infections in a teaching hospital in Ujjain, India. Am J Infect Control. 2014;42(1):e11–5.CrossRef
Zurück zum Zitat Sharma M, Eriksson B, Marrone G, Dhaneria S, Lundborg CS. Antibiotic prescribing in two private sector hospitals; one teaching and one non-teaching: a cross-sectional study in Ujjain, India. BMC Infect Dis. 2012;12:155.CrossRef Sharma M, Eriksson B, Marrone G, Dhaneria S, Lundborg CS. Antibiotic prescribing in two private sector hospitals; one teaching and one non-teaching: a cross-sectional study in Ujjain, India. BMC Infect Dis. 2012;12:155.CrossRef
Zurück zum Zitat Shojania KG, Duncan BW, McDonald KM, Wachter RM, Markowitz AJ. Making health care safer: a critical analysis of patient safety practices. Evid Rep Technol Assess (Summ). 2001;(43):i–x 1-668. Shojania KG, Duncan BW, McDonald KM, Wachter RM, Markowitz AJ. Making health care safer: a critical analysis of patient safety practices. Evid Rep Technol Assess (Summ). 2001;(43):i–x 1-668.
Zurück zum Zitat Tamhankar AJ, Karnik SS, Stalsby Lundborg C. Determinants of Antibiotic Consumption - Development of a Model using Partial Least Squares Regression based on Data from India. Sci Rep. 2018;8(1):6421.CrossRef Tamhankar AJ, Karnik SS, Stalsby Lundborg C. Determinants of Antibiotic Consumption - Development of a Model using Partial Least Squares Regression based on Data from India. Sci Rep. 2018;8(1):6421.CrossRef
Zurück zum Zitat Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742–50.CrossRef Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742–50.CrossRef
Zurück zum Zitat Vessal G, Namazi S, Davarpanah MA, Foroughinia F. Evaluation of prophylactic antibiotic administration at the surgical ward of a major referral hospital, Islamic Republic of Iran. East Mediterr Health J. 2011;17(8):663–8.CrossRef Vessal G, Namazi S, Davarpanah MA, Foroughinia F. Evaluation of prophylactic antibiotic administration at the surgical ward of a major referral hospital, Islamic Republic of Iran. East Mediterr Health J. 2011;17(8):663–8.CrossRef
Zurück zum Zitat World Health Organization. International Statistical Classification of Disease and Related Health Problems - 10th revision. 2010. World Health Organization. International Statistical Classification of Disease and Related Health Problems - 10th revision. 2010.
Zurück zum Zitat World Health Organization. Report on the Burden of Endemic Health Care-Associated Infection Worldwide. 2011. World Health Organization. Report on the Burden of Endemic Health Care-Associated Infection Worldwide. 2011.
Zurück zum Zitat World Health Organization. The evolving threat of antimicrobial resistance: options for action: World Health Organization; 2012. World Health Organization. The evolving threat of antimicrobial resistance: options for action: World Health Organization; 2012.
Metadaten
Titel
Perioperative antibiotic prescribing in surgery departments of two private sector hospitals in Madhya Pradesh, India
verfasst von
Anna Machowska
Jonatan Sparrentoft
Shyam Kumar Dhakaita
Cecilia StålsbyLundborg
Megha Sharma
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
Perioperative Medicine / Ausgabe 1/2019
Elektronische ISSN: 2047-0525
DOI
https://doi.org/10.1186/s13741-019-0121-3

Weitere Artikel der Ausgabe 1/2019

Perioperative Medicine 1/2019 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Häufigste Gründe für Brustschmerzen bei Kindern

06.05.2024 Pädiatrische Diagnostik Nachrichten

Akute Brustschmerzen sind ein Alarmsymptom par exellence, schließlich sind manche Auslöser lebensbedrohlich. Auch Kinder klagen oft über Schmerzen in der Brust. Ein Studienteam ist den Ursachen nachgegangen.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.